306 related articles for article (PubMed ID: 34516235)
1. Mucosal Immunization with DTaP Confers Protection against
Hall JM; Bitzer GJ; DeJong MA; Kang J; Wong TY; Wolf MA; Bevere JR; Barbier M; Damron FH
Infect Immun; 2021 Nov; 89(12):e0034621. PubMed ID: 34516235
[TBL] [Abstract][Full Text] [Related]
2. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
3. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
Front Immunol; 2018; 9():51. PubMed ID: 29416544
[TBL] [Abstract][Full Text] [Related]
4. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
5. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
6. BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models.
DeJong MA; Wolf MA; Bitzer GJ; Hall JM; Fitzgerald NA; Pyles GM; Huckaby AB; Petty JE; Lee K; Barbier M; Bevere JR; Ernst RK; Damron FH
Infect Immun; 2024 Mar; 92(3):e0022323. PubMed ID: 38323817
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
[No Abstract] [Full Text] [Related]
8. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
[TBL] [Abstract][Full Text] [Related]
9. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
Front Immunol; 2022; 13():878832. PubMed ID: 35493458
[TBL] [Abstract][Full Text] [Related]
11. Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.
Martin Aispuro P; Bottero D; Zurita ME; Gaillard ME; Hozbor DF
Front Immunol; 2023; 14():1192119. PubMed ID: 37435078
[TBL] [Abstract][Full Text] [Related]
12. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
[TBL] [Abstract][Full Text] [Related]
13. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
[TBL] [Abstract][Full Text] [Related]
14. Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics.
Hendrikx LH; Öztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM
PLoS One; 2011; 6(11):e27681. PubMed ID: 22110718
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
17. Reinvestigating the Coughing Rat Model of Pertussis To Understand
Hall JM; Kang J; Kenney SM; Wong TY; Bitzer GJ; Kelly CO; Kisamore CA; Boehm DT; DeJong MA; Wolf MA; Sen-Kilic E; Horspool AM; Bevere JR; Barbier M; Damron FH
Infect Immun; 2021 Nov; 89(12):e0030421. PubMed ID: 34125597
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
Weaver KL; Blackwood CB; Horspool AM; Pyles GM; Sen-Kilic E; Grayson EM; Huckaby AB; Witt WT; DeJong MA; Wolf MA; Damron FH; Barbier M
Front Immunol; 2022; 13():838504. PubMed ID: 35211125
[TBL] [Abstract][Full Text] [Related]
19. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
Wanlapakorn N; Maertens K; Chaithongwongwatthana S; Srimuan D; Suratannon N; Vongpunsawad S; Tran TMP; Hens N; Van Damme P; Locht C; Poovorawan Y; Leuridan E
Vaccine; 2018 Mar; 36(11):1453-1459. PubMed ID: 29426663
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
